Novan (NOVN) Tops Q2 EPS by 16c

Go back to Novan (NOVN) Tops Q2 EPS by 16c

Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 11, 2022 6:30 AM EDT

Total revenue of $6.2 million for the second quarter 2022

Activities on track for submission of berdazimer gel, 10.3% (SB206) New Drug Application (NDA), targeting submission before the end of 2022

Company to host conference call today at 8:30 a.m. ET

DURHAM, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (the Company or Novan) (Nasdaq: NOVN), today announced its financial and operating results for the second quarter ended June 30, 2022 and provided a corporate update. The Company will host a conference call and webcast, today, August 11, 2022, at 8:30 a.m. ET (details... More